Drug Substance
IDENTIFICATION, SEPARATION AND CHARACTERIZATION OF POTENTIAL DEGRADATION PRODUCTS IN ACOTIAMIDE DRUG SUBSTANCE
... LC-MS analysis was carried out on the alkaline degradation drug substance of ACOT using following conditions. Mobile phase 0.1 % triethylamine with 0.2 % formic acid: acetonitrile /with the gradient ...
7
Bibliography of Drug, Substance and Alcoholic Abuse
... of drug, substance and alcoholic abuse on the society are also seen in the area of crime – like stealing, assault, violence, demonstrations, students‟ unrests, rape and armed robbery, low productivity and ...
14
Development and Validation of Stability Indicating HPLC Method for the Determination of Process and Degradation Related Impurities in Telmisartan Drug Substance
... A new sensitive, specific, precise and accurate stability indicating reverse phase high performance liquid chromatographic (RP-HPLC) method was developed and validated for the determination of related substances of ...
21
Spectrophotometric Determination of Ibutilide Fumarate in Bulk Drug substance form
... experimental parameters for the reaction were studied and also validity of the described procedure was assessed. The statistical analysis of results revealed high accuracy and good precision. The proposed method was ...
5
Identification and characterization of new impurity in Cefotaxime Sodium drug substance
... amino-4-thiazolyl)-2-(methoxyimino)acetamido]-3-acetyl-oxymethyl-3-cephem-4-carboxylate. During the HPLC analysis of Cefotaxime Sodium, one unknown impurity was detected along with six pharmacopoeial impurities [8] level ...
12
DEVELOPMENT AND VALIDATION OF SIMPLE EFFECTIVE HPLC METHOD FOR THE QUANTITATIVE DETERMINATION OF RELATED SUBSTANCE PRESENT IN SITAGLIPTIN PHOSPHATE DRUG SUBSTANCE
... Phosphate drug substance under stress conditions like oxidation,10% H2O2, acid, base, Photolytic(White fluorescent light, 10K Lux and UV light, 200watt- hr/m2), thermal (105°C) and humidity (at 90% RH/25°C) ...
10
Synthesis and characterization of potential impurit ies in Fenofibrate drug substance
... a drug product is not only dependent on the toxicological properties of the active drug substance (or API), but also on the impurities formed during the various chemical synthesis or formulation ...
6
Mat-CHN software for drug substance titrations in discovery and development
... Analysis is the unique analytical technique used to make absolute assays at this stage of the value chain, is now con- solidated when combined with Mat-CHN. This software is probably one of the first able to reconcile ...
17
DEVELOPMENT OF STABILITY INDICATING ASSAY METHOD: A REVIEW
... with drug shows severe toxic effects, which causes death ...effective drug products for human use, there is great need of maintains its purity and quality of drug substance at any storage ...
7
FORCED DEGRADATION STUDIES DEVELOPMENT AND VALIDATION BY RP-HPLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF COMBINATION DRUGS ELBASVIR AND GRAZOPREVIR IN BULK AND PHARMACEUTICAL DOSAGE FORMSSwapna.Goday*, S.K.Abdul Rahaman, A.PrameelaraniDOWNLOAD/VIEW
... of drug substance and helps in structural elucidation of degradation ...of drug substance or drug ...of drug from degradation ...new drug substances and products should be ...
8
Dosage forms.ppt
... • Besides the choice of the active drug substance, you need to also make a responsible decision regarding the route of administration and the DOSAGE FORM (drug delivery system) – wrong[r] ...
42
Continuous manufacturing of high quality pharmaceutical cocrystals integrated with process analytical tools for in-line process control
... a drug substance such as stability, solubility, and bio- ...a drug substance by altering the crystal packing through drug − conformer supramolecular interactions has led to the ...
16
Force Degradation Study of Rizatriptan Benzoate by Rp- HPLC Method and Characterization of Degraded Product
... As out lived by ICH guidelines, identification, isolation of impurity is very important task during drug synthesis and storage. It can provide crucial toxicology and safety data of finished drug and dosage ...
7
A COMPARATIVE STUDY OF LEDIPASVIR SOLID DISPERSION TECHNIQUE USING SPRAY DRYING AND HOT MELT EXTRUSION
... MATERIALS AND METHODS: Harvoni ® (Marketed Product) tablets were obtained from Gilead sciences, Inc., Foster City, CA Made in Ireland. Ledipasvir drug substance was gifted by Hetero Drugs Ltd., Hyderabad, ...
10
APPLICATION OF QUALITY BY DESIGN TO DIFFERENT ASPECTS OF PHARMACEUTICAL TECHNOLOGIES
... the drug product such as strength and dosage form, which are not the part of CQA as it will not change during drug development ...of drug substance and drug product are enlisted in ...
14
BIOEQUIVALENCE AND BIOAVAILABILITY STUDY OF ANTIHYPERTENSIVE DRUG: A REVIEW
... administered drug products can be documented by developing a systemic exposure ...the drug substance from the drug product and a series of possible presystemic/systemic actions on the ...
10
STABILITY STUDY OF LIQUID PARAFFIN ORAL EMULSION (CREMAFFIN)
... a drug substance or drug product as the Drug products varies with time, Under the influence of a variety of enviromental factors such as temperature, humidity and ...the drug ...
6
International Conference on Harmonisation Guidelines for Regulation of Pharmaceutical Impurities in New Drug Substances
... a drug substance impurity does not exist in the compendial monograph and this impurity can be qualified by comparison with an Health (FDA) approved human drug product, it is important that the ...
5
NOVEL MULTIPARTICULATE DRUG DELIVERY SYSTEM OF CARVEDILOL AS ANTIHYPERTENSIVE DRUG
... The layering stage includes depositing of successive layering of active entities from suspension or solution on nuclei (pellets of inert material/sugar spheres). Solution layering includes depositing of respective layers ...
7
Identifying perceived barriers to monitoring service quality among substance abuse treatment providers in South Africa
... African substance abuse treatment providers are prepared to im- plement a performance measurement system that will enable them to assess the quality of services they pro- vide, even if this implementation compels ...
10